+1,100.9%
MRNA vs ACGL
+317.3%
+783.6%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ACGL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.3% | -3.8% | -3.4% |
| 7D | -12.1% | +2.2% | -14.3% | -12.1% |
| 30D | -1.3% | +12.3% | -13.6% | -1.2% |
| 3M | +250.9% | +11.8% | +239.1% | +251.4% |
| 6M | +343.0% | +17.5% | +325.6% | +343.3% |
| YTD | +657.4% | +14.3% | +643.2% | +657.9% |
| 1Y | +794.9% | +18.2% | +776.7% | +794.7% |
| 3Y | +218.1% | +33.2% | +185.0% | +218.0% |
| 5Y | -3.4% | +174.3% | -177.7% | -2.8% |
| All | +1,100.9% | +317.3% | +783.6% | +865.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ACGL.
Daily Out/Under-Performance
Portfolio return minus ACGL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ACGL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ACGL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling